Award

Metabolism-based dissection of tumor microenvironment infiltrated by immune cells

Description: We found that anti-tumor effect of anti-PD-1 antibody was enhanced by combination with type 2 diabetes drug metformin. As one of the mechanisms, we found that tumor-infiltrating CD8T cells (CD8TIL) have a marked proliferative response and enhanced IFNγ production. This reaction was demonstrated to occur as part of the antioxidant stress response (active oxygen scavenging reaction) mediated by the Nrf2/mTORC1/p62 molecular group in CD8TIL by metformin. This study elucidated a completely new mechanism of the antitumor effect of metformin.
Amount: ¥43,810,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (A)
Start date: 2018-04-01
End date: 2023-03-31
Investigator: Heiichiro UDONO
Institution: Okayama University
Funded outputs count: 17
Funder award ID: 18H04033
OpenAlex ID: G4016162594
2026 · Natsumi Imano, Mikako Nishida, et al. · British Journal of Pharmacology
2024 · Miho Tokumasu, Mikako Nishida, et al. · Proceedings of the National Academy of Sciences · 17
2024 · CHAO, RUOYU · Okayama University Scientific Achievement Repository (Okayama University)
2022 · Kazuya Nishii, Kadoaki Ohashi, et al. · Cancer Immunology Research · 26
2022 · Heiichiro Udono, Mikako Nishida · Biochimica et Biophysica Acta (BBA) - General Subjects · 27
2019 · TAKANORI HIRAYAMA, YASUHIRO NAGATA, et al. · Anticancer Research · 11
2009 · Alessandra Grandelis · Padua Research Archive (University of Padova)
Year
Topic